Skip to content

Clinical trials

Phase 1/2 Diabetes Mellitus, Type 1 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 1/2 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20091
20102
20121
20131
20161
20171
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fuzhou General Hospital3
Second Xiangya Hospital of Central South University2
EndoCell Therapeutics, Inc.1
European Foundation for the Study of Diabetes1
Qingdao University1
S-Evans Biosciences Co., Ltd.1
Shandong University1
Throne Biotechnologies Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 111
Diabetes Mellitus2
Diabetes Mellitus, Type 21
Hypoglycemia1
Kidney Failure, Chronic1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.